The Use of Recombinant Factor VIIa in Controlling Surgical Bleeding in Non-Haemophiliac Patients

Publisher： Karger

E-ISSN： 1424-8840|32|1|41-46

ISSN： 1424-8832

Source： Pathophysiology of Haemostasis and Thrombosis, Vol.32, Iss.1, 2002-05, pp. : 41-46

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treatment of Bleeding in Patients with Platelet Disorders: Is There a Place for Recombinant Factor VIIa?

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 32, Iss. 1, 2002-05 ,pp. : 37-40

Karger

Access to resources Recommend Favorite

Use of Recombinant Factor VIIa in Patients With Warfarin-Associated Intracranial Hemorrhage

By Brody David L.   Aiyagari Venkatesh   Shackleford Angela M.   Diringer Michael N.  

Neurocritical Care, Vol. 2, Iss. 3, 2005-06 ,pp. : 263-267

Humana Press, Inc

Access to resources Recommend Favorite

Successful Use of Recombinant Factor VIIa for Massive Bleeding after Caesarean Section due to HELLP Syndrome

By  

Acta Haematologica, Vol. 108, Iss. 3, 2002-09 ,pp. : 162-163

Karger

Access to resources Recommend Favorite

More on: platelet count and the Use of Recombinant Factor VIIa for the treatment of Bleeding Complications after Hematopoietic Stem Cell Transplantation

By  

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol. 4, Iss. 1, 2006-01 ,pp. : 288-288

John Wiley & Sons Inc

Access to resources Recommend Favorite

Recombinant Factor VIIa Reduces Bleeding Risk in Patients on Platelet Aggregation Inhibitors Immediately prior to Renal Transplantation – A Retrospective Analysis

By  

Urologia Internationalis, Vol. 78, Iss. 2, 2007-02 ,pp. : 135-139

Karger

Access to resources Recommend Favorite